Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

SQI Diagnostics Inc > This is Our Moment
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(19)
•••
Comment by ResearchGuyon Nov 11, 2022 8:03pm
125 Views
Post# 35093002

RE:This is Our Moment

RE:This is Our Moment

As much as I would love to see the SP move in a northerly direction Drastically and sooner rather than later,  it is more important at the moment to ensure that our little ones are looked after immediately. They depend on us to ensure that we keep them healthy and do everything we can and use our best efforts to take care of them. 

Now is not the time for politics and certainly not the time for all the red tape. it's time to start implementing and using equipment that we have at our disposal to do everything we can to address the needs at hand. 

These articles just keep pouring in minute by minute now. Someone needs to light a fire under whoever makes the decisions and let them know SQI has what it takes to help in a big way.

Am I missing something here and out to lunch believing that SQI can make a difference. Someone enlighten me and tell me I am right !!

https://apple.news/AFACimYMSRCmWYL6V-tgZ1g

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities